OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Chimeric antigen receptor engineered natural killer cells for cancer therapy
Yalan Zhang, Weilin Zhou, Jianping Yang, et al.
Experimental Hematology and Oncology (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 25
Yalan Zhang, Weilin Zhou, Jianping Yang, et al.
Experimental Hematology and Oncology (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 25
Showing 25 citing articles:
The CAR macrophage cells, a novel generation of chimeric antigen-based approach against solid tumors
Kaveh Hadiloo, Siavash Taremi, Mahmood Heidari, et al.
Biomarker Research (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 39
Kaveh Hadiloo, Siavash Taremi, Mahmood Heidari, et al.
Biomarker Research (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 39
The power and the promise of CAR-mediated cell immunotherapy for clinical application in pancreatic cancer
Haoyu Tang, Yizhi Cao, Yiwei Zhou, et al.
Journal of Advanced Research (2024)
Open Access | Times Cited: 8
Haoyu Tang, Yizhi Cao, Yiwei Zhou, et al.
Journal of Advanced Research (2024)
Open Access | Times Cited: 8
Targeting natural killer cells: from basic biology to clinical application in hematologic malignancies
Juanjuan Shang, Shunfeng Hu, Xin Wang
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 8
Juanjuan Shang, Shunfeng Hu, Xin Wang
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 8
NK cell transfer overcomes resistance to PD-(L)1 therapy in aged mice
Junlei Hou, Shuanglong Xie, Jianbao Gao, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 7
Junlei Hou, Shuanglong Xie, Jianbao Gao, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 7
Beyond CAR T cells: exploring alternative cell sources for CAR-like cellular therapies
Christina Angeliki Tsiverioti, Adrian Gottschlich, Marcel P. Trefny, et al.
Biological Chemistry (2024) Vol. 405, Iss. 7-8, pp. 485-515
Open Access | Times Cited: 7
Christina Angeliki Tsiverioti, Adrian Gottschlich, Marcel P. Trefny, et al.
Biological Chemistry (2024) Vol. 405, Iss. 7-8, pp. 485-515
Open Access | Times Cited: 7
CAR T cells outperform CAR NK cells in CAR-mediated effector functions in head-to-head comparison
Lukas Egli, Meike Kaulfuß, Juliane Mietz, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 6
Lukas Egli, Meike Kaulfuß, Juliane Mietz, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 6
Next-Generation CEA-CAR-NK-92 Cells against Solid Tumors: Overcoming Tumor Microenvironment Challenges in Colorectal Cancer
Alexander Sebastian Franzén, Abdelhadi Boulifa, Clarissa Radecke, et al.
Cancers (2024) Vol. 16, Iss. 2, pp. 388-388
Open Access | Times Cited: 5
Alexander Sebastian Franzén, Abdelhadi Boulifa, Clarissa Radecke, et al.
Cancers (2024) Vol. 16, Iss. 2, pp. 388-388
Open Access | Times Cited: 5
Chimeric Antigen Receptor Cell Therapy: Empowering Treatment Strategies for Solid Tumors
Tang‐Her Jaing, Yi-Wen Hsiao, Yi-Lun Wang
Current Issues in Molecular Biology (2025) Vol. 47, Iss. 2, pp. 90-90
Open Access
Tang‐Her Jaing, Yi-Wen Hsiao, Yi-Lun Wang
Current Issues in Molecular Biology (2025) Vol. 47, Iss. 2, pp. 90-90
Open Access
Pei Guo, Liyuan Zhong, Tao Wang, et al.
Scandinavian Journal of Immunology (2025) Vol. 101, Iss. 2
Closed Access
Enhanced cellular therapy: revolutionizing adoptive cellular therapy
Mengyao Xu, Na Zeng, Chen‐Qian Liu, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 4
Mengyao Xu, Na Zeng, Chen‐Qian Liu, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 4
Single VHH-directed BCMA CAR-NK cells for multiple myeloma
Quan Ren, Yingling Zu, Hongchang Su, et al.
Experimental Hematology and Oncology (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 11
Quan Ren, Yingling Zu, Hongchang Su, et al.
Experimental Hematology and Oncology (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 11
Antitumor activity of genetically engineered NK-cells in non-hematological solid tumor: a comprehensive review
Chinmayee Dash, Dhruba Sonowal, Prachi Dhaka, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 3
Chinmayee Dash, Dhruba Sonowal, Prachi Dhaka, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 3
RAC1high NK cell-based immunotherapy in hepatocellular carcinoma via STAT3-NKG2D axis
Xiaoli Shi, Weiwen Chen, Yefeng Yin, et al.
Cancer Letters (2024) Vol. 592, pp. 216909-216909
Closed Access | Times Cited: 3
Xiaoli Shi, Weiwen Chen, Yefeng Yin, et al.
Cancer Letters (2024) Vol. 592, pp. 216909-216909
Closed Access | Times Cited: 3
CAR-NK Cell Therapy: A Transformative Approach to Overcoming Oncological Challenges
Wangshu Li, Xiuying Wang, Xu Zhang, et al.
(2024)
Open Access | Times Cited: 3
Wangshu Li, Xiuying Wang, Xu Zhang, et al.
(2024)
Open Access | Times Cited: 3
Combining the induced pluripotent stem cell (iPSC) technology with chimeric antigen receptor (CAR)-based immunotherapy: recent advances, challenges, and future prospects
Mehdi Alidadi, Haniyeh Barzgar, Mohammad Asif Zaman, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 3
Mehdi Alidadi, Haniyeh Barzgar, Mohammad Asif Zaman, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 3
CAR-NK Cell Therapy: A Transformative Approach to Overcoming Oncological Challenges
Wangshu Li, Xiuying Wang, Xu Zhang, et al.
Biomolecules (2024) Vol. 14, Iss. 8, pp. 1035-1035
Open Access | Times Cited: 2
Wangshu Li, Xiuying Wang, Xu Zhang, et al.
Biomolecules (2024) Vol. 14, Iss. 8, pp. 1035-1035
Open Access | Times Cited: 2
Non-viral approaches in CAR-NK cell engineering: connecting natural killer cell biology and gene delivery
Emma McErlean, Helen O. McCarthy
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 1
Emma McErlean, Helen O. McCarthy
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 1
Targeting CD5 chimeric antigen receptor-engineered natural killer cells against T-cell malignancies
Yingling Zu, Quan Ren, Jishuai Zhang, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 1
Yingling Zu, Quan Ren, Jishuai Zhang, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 1
Natural Killer Cells in Cancers of Respiratory System and Their Applications in Therapeutic Approaches
Maryam Dokhanchi, Atefe Panahipoor Javaherdehi, Mohammad Raad, et al.
Immunity Inflammation and Disease (2024) Vol. 12, Iss. 11
Open Access | Times Cited: 1
Maryam Dokhanchi, Atefe Panahipoor Javaherdehi, Mohammad Raad, et al.
Immunity Inflammation and Disease (2024) Vol. 12, Iss. 11
Open Access | Times Cited: 1
The development and application of chimeric antigen receptor natural killer (CAR-NK) cells for cancer therapy: current state, challenges and emerging therapeutic advances
Pin Mei Yao, Yaguang Liu, Gang Huang, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 1
Pin Mei Yao, Yaguang Liu, Gang Huang, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 1
Cell-Based Vaccines: Frontiers in Medical Technology for Cancer Treatment
Babak Arjmand, Sepideh Alavi-Moghadam, Golnar Khorsand, et al.
Regenerative Engineering and Translational Medicine (2024)
Closed Access
Babak Arjmand, Sepideh Alavi-Moghadam, Golnar Khorsand, et al.
Regenerative Engineering and Translational Medicine (2024)
Closed Access
Beyond CAR-T: The rise of CAR-NK cell therapy in asthma immunotherapy
Mohadeseh Mohammad Taheri, Fatemeh Javan, Mohadeseh Poudineh, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access
Mohadeseh Mohammad Taheri, Fatemeh Javan, Mohadeseh Poudineh, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access
CAR natural killer cell therapy: Natural killer cell activation and expansion
Polina Fedorova
Acta Biomedica Scientifica (East Siberian Biomedical Journal) (2024) Vol. 9, Iss. 5, pp. 53-65
Open Access
Polina Fedorova
Acta Biomedica Scientifica (East Siberian Biomedical Journal) (2024) Vol. 9, Iss. 5, pp. 53-65
Open Access
Clinical Application of Umbilical Cord Blood NK Cells in the Treatment of Liver Cancer
春涛 吴
Journal of Clinical Personalized Medicine (2024) Vol. 03, Iss. 04, pp. 2277-2283
Open Access
春涛 吴
Journal of Clinical Personalized Medicine (2024) Vol. 03, Iss. 04, pp. 2277-2283
Open Access
Development of CAR-NK Cells Targeting cSCC-Specific Antigens for Precision Immunotherapy
Akram Tayanloo-Beik, Peyvand Parhizkar Roudsari, Hamid Reza Aghayan, et al.
Methods in molecular biology (2023), pp. 253-263
Closed Access
Akram Tayanloo-Beik, Peyvand Parhizkar Roudsari, Hamid Reza Aghayan, et al.
Methods in molecular biology (2023), pp. 253-263
Closed Access
